Search

Search Constraints

You searched for: Author/Creator Frigault, Matthew J.

Search Results

1. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. Issue 1 (14th November 2019)

2. Detection of CAR‐T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories. Issue 6 (29th April 2021)

3. Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients. (30th July 2021)

4. Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients. (30th July 2021)

5. Immune checkpoint inhibitors for cancer and venous thromboembolic events. (November 2021)

6. Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T‐cell therapy. Issue 3 (1st December 2022)

7. Successful anti‐CD19 CAR T‐cell therapy in HIV‐infected patients with refractory high‐grade B‐cell lymphoma. Issue 21 (10th September 2019)